Amy Ramsey

13PUBLICATIONS
39CO-AUTHORS
NeurogeneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Cell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 19, 2026
Neurodevelopmental disorder-causing GRIN1 Y647S variant alters red blood cell physiology in mice.

Sylvia C Okafor, Wendy Horsfall, Peter S B Finnie

|Jul 23, 2025
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction.

Mathieu Oosterlaken, Angelina Rogliardo, Tatiana Lipina

|Jul 26, 2024
Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Xunan Wang, Ilias Marmouzi, Peter S B Finnie

|Oct 24, 2023
Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Xunan Wang, Ilias Marmouzi, Peter Sb Finnie

|Jun 22, 2023
Deficits in integrative NMDA receptors caused by Grin1 disruption can be rescued in adulthood.

Sridevi Venkatesan, Mary A Binko, Catharine A Mielnik

|May 04, 2023
Evaluation and Validation of Commercially Available Dopamine Transporter Antibodies.

Emma E Russo, Lola E Zovko, Reza Nazari

Pageof 3